AI analyzes Reddit posts to find underreported GLP-1 side effects
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with…
An implantable living pharmacy produces drugs in the body
Scientists at Northwestern University, Rice University, and Carnegie Mellon University have made a device that can be…
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients…
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…
How Donald Trump’s New Drug Tariffs Could Affect Prescription Prices
President Donald Trump signed an executive order Thursday setting the stage for tariffs as high as 100 percent…
FDA declines to issue specific guidance on drug importation by AFPs
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
Trump sets 100% tariffs on prescription drugs from companies that have not reached a deal with him to lower prices
President Donald Trump has set 100 percent tariffs on prescription drugs from overseas companies that have not reached…
Trump tariffs fall, but trade war impacts linger
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
Lilly’s weight-loss pill wins FDA approval
For the first time, regulators have approved a small-molecule pill targeting glucagon-like peptide1 (GLP-1) for weight loss.…
Novo Nordisk stock rises after Wegovy recommended by UK’s drug price regulator
Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…
Eli Lilly to acquire Centessa and sleep disorder drugs
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug…